Related Funds
| Fund Name | Location |
| Alkemi Venture Partners | Delhi, India, New Delhi |
| Boyser SRL | Barcelona, Catalonia, Spain |
| CITIC Medical Fund | - |
| Coface | Bois-colombes, France, Ile-de-France |
| E-Synergy | California, Los Angeles, United States |
| Federal-Mogul Motorparts | - |
| First Stone Venture Partners | - |
| Gaia Securitizations | - |
| Huaxi Xinyu Investment | China, Fujian, Hunan |
| Huckletree Alpha Programme London | England, London, United Kingdom |
| Knygt Erraunt LLC | California, Novato, United States |
| MC2 | - |
| Meridian Asset Management | Salt Lake City, United States, Utah |
| Morningside Capital | Chicago, Illinois, United States |
| Purify | - |
| Sarava | Iran, Tehran, Tehran County |
| Sathguru Catalyzer Advisors | Andhra Pradesh, Hyderabad, India |
| SOUL FI | Lisboa, Lisbon, Portugal |
| Tianjin Pusi Zi Guan | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Relation Therapeutics | $35M | 14 Mar 2024 | London, England, United Kingdom | ||
Paradigm | $203M | 25 Jan 2023 | New York, New York, United States | ||
Project Eaden | $9M | 30 Jun 2022 | Berlin, Berlin, Germany | ||
Relation Therapeutics | $25M | 09 Jun 2022 | London, England, United Kingdom | ||
Transition Bio | $50M | 02 Jun 2022 | Cambridge, Massachusetts, United States | ||
Spotlight Therapeutics | $36M | 22 Mar 2022 | Hayward, California, United States | ||
Resilience | $80M | 22 Nov 2021 | San Diego, California, United States | ||
Deep Genomics | $180M | 28 Jul 2021 | Old Toronto, Ontario, Canada | ||
HiberCell | $67M | 19 May 2021 | New York, New York, United States |
– Deep Genomics announced the closing of a $180m Series C financing round.
– The round was led by SoftBank Vision Fund 2 and includes participation from new investors, Canadian Pension Plan Investment Board, Fidelity Management & Research Company, Alexandria Venture Investments, and existing investors Amplitude Ventures, Khosla Ventures, Magnetic Ventures, and True Ventures.
– Deep Genomics uses AI and machine learning to program and prioritize transformational RNA therapeutics for genetic diseases.
– The company has leveraged its strategic geographical advantage by combining its teams in Toronto, the birthplace of deep learning and the fastest growing technology hub in North America, with the Boston-Cambridge biotechnology hub, by hiring Jeffrey Brown, PhD, as VP of Preclinical Research, Ferdinand Massari, MD, as Chief Medical Officer, and Amanda Kay, PhD, as Chief Business Officer.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Relation Therapeutics | $35M | 14 Mar 2024 | London, England, United Kingdom | ||
Paradigm | $203M | 25 Jan 2023 | New York, New York, United States | ||
Project Eaden | $9M | 30 Jun 2022 | Berlin, Berlin, Germany | ||
Relation Therapeutics | $25M | 09 Jun 2022 | London, England, United Kingdom | ||
Transition Bio | $50M | 02 Jun 2022 | Cambridge, Massachusetts, United States | ||
Spotlight Therapeutics | $36M | 22 Mar 2022 | Hayward, California, United States | ||
Resilience | $80M | 22 Nov 2021 | San Diego, California, United States | ||
Deep Genomics | $180M | 28 Jul 2021 | Old Toronto, Ontario, Canada | ||
HiberCell | $67M | 19 May 2021 | New York, New York, United States |
